Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Renovion, Inc logo — Restoring Lung Health, One Breath at a Time

Renovion, Inc

Restoring Lung Health, One Breath at a Time

Founded 2013 United States Chapel Hill, United States 5 employees Venture round Total: $29.38M Health Care, Pharmaceutical

General Information

Company Name Renovion, Inc
Founded Year 2013
Location United States Chapel Hill, United States
Employees 5
Industries Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Renovion, Inc. To contact Renovion, Inc, visit renovion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Renovion, Inc compare?

A PDF of Renovion, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Renovion, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Renovion, Inc

Renovion, Inc is a clinical-stage company dedicated to advancing therapies that restore lung health. Their slogan, "Restoring Lung Health, One Breath at a Time," captures their commitment to making a meaningful impact in the healthcare industry. Founded in 2013 and headquartered in the United States, Renovion focuses on the Health Care and Pharmaceutical sectors. Their product, ARINA·1, addresses the needs of individuals with a lung transplant, non-cystic fibrosis bronchiectasis (NCFBE), non-tuberculous mycobacteria-lung disease (NTM-LD), and Tracheostomy. The company recently received a significant $15.02M Venture Round investment on 28 March 2023. Although the details of the investors are not provided, this injection of capital signifies confidence in Renovion's vision and potential to deliver impactful solutions in the lung health space. With its focus on addressing critical unmet needs in respiratory health, Renovion's innovative approach and recent investment demonstrate its potential to make a significant mark in the healthcare industry.

Business keywords: Lung Health, Gene Therapy, Clinical-Stage Company, Nebulizer Therapy, Lung Transplant, Therapeutics, Respiratory Diseases, Healthcare Innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $15.02M -
28 Mar 2023
Series A $8.10M 1
Whiterock Capital
Whiterock Capital
18 Jun 2020
Series A Undisclosed 1
Texas Halo Fund
Texas Halo Fund
27 Apr 2020
Venture Round $4.95M -
14 Feb 2020
Venture Round $492.20K -
08 Feb 2019
Venture Round $350.00K -
15 May 2018
Seed Round $467.49K -
01 Sep 2016

Renovion, Inc Alternatives & Competitors

View All Alternatives
Renovion, Inc vs
Microbion Corporation
Microbion Corporation United States

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serio...

Venture round
16 employees
Biotechnology, Health Care
Renovion, Inc vs
Jasper Therapeutics
Jasper Therapeutics United States

Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat chronic di...

IPO
41 employees
Biotechnology, Health Care
Renovion, Inc vs
Handl Therapeutics
Handl Therapeutics Belgium

Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through academic a...

Grant
Biotechnology, Health Care
View all alternatives

FAQ About Renovion, Inc

Restoring Lung Health, One Breath at a Time
Renovion, Inc was founded in 2013.
Renovion, Inc is headquartered in Chapel Hill, United States.
Renovion, Inc operates in Health Care and Pharmaceutical. Its work centres on Lung Health, Gene Therapy, Clinical-Stage Company and Nebulizer Therapy.
Renovion, Inc has approximately 5 employees.
Renovion, Inc has completed 7 funding rounds, raising a total of $29.38M. The latest funding stage is Venture round.
Top alternatives and competitors to Renovion, Inc include Microbion Corporation, Jasper Therapeutics, Handl Therapeutics, Chance Pharmaceuticals 畅溪制药, AGTC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Renovion, Inc and Microbion Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Renovion, Inc, https://bouncewatch.com/company/renovion-inc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout